As the stock market capped a week-long rally, several dozen stocks made new highs. The medical sector continues to attract institutional funds, accounting for 10 of Friday's new highs. Gilead Sciences (GILD) inched up to its new high. The stock has become extended from its 70.49 buy point in a flat base. Although the biotech industry has been performing well, Gilead doesn't have the group's strongest fundamentals. Its earnings fell 2% in the third